Goldman Sachs
LUNG icon

Goldman Sachs’s Pulmonx LUNG Stock Holding History

Goldman Sachs’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Sell
135,343
-88,107
-39% -$121K ﹤0.01% 6231
2026
Q1 		$288K Sell
223,450
-141,753
-39% -$234K ﹤0.01% 5912
2025
Q4 		$807K Sell
365,203
-29,687
-8% -$55.8K ﹤0.01% 5279
2025
Q3 		$640K Buy
394,890
+184,413
+88% +$386K ﹤0.01% 5346
2025
Q2 		$545K Buy
210,477
+13,978
+7% +$55.1K ﹤0.01% 5109
2025
Q1 		$1.32M Sell
196,499
-47,048
-19% -$333K ﹤0.01% 4485
2024
Q4 		$1.65M Sell
243,547
-10,209
-4% -$67.2K ﹤0.01% 4449
2024
Q3 		$2.1M Buy
253,756
+11,837
+5% +$85.7K ﹤0.01% 4111
2024
Q2 		$1.53M Buy
241,919
+27,307
+13% +$210K ﹤0.01% 4134
2024
Q1 		$1.99M Sell
214,612
-37,802
-15% -$443K ﹤0.01% 3868
2023
Q4 		$3.22M Buy
252,414
+140,119
+125% +$1.46M ﹤0.01% 3547
2023
Q3 		$1.16M Sell
112,295
-111,681
-50% -$1.29M ﹤0.01% 4167
2023
Q2 		$2.94M Buy
223,976
+71,946
+47% +$880K ﹤0.01% 3572
2023
Q1 		$1.7M Sell
152,030
-189,494
-55% -$1.87M ﹤0.01% 3986
2022
Q4 		$2.88M Sell
341,524
-333,210
-49% -$3.17M ﹤0.01% 3646
2022
Q3 		$11.2M Buy
674,734
+233,630
+53% +$4.3M ﹤0.01% 2396
2022
Q2 		$6.49M Sell
441,104
-59,918
-12% -$1.23M ﹤0.01% 2898
2022
Q1 		$12.4M Buy
501,022
+395,566
+375% +$10.2M ﹤0.01% 2469
2021
Q4 		$3.38M Sell
105,456
-48,248
-31% -$1.76M ﹤0.01% 3784
2021
Q3 		$5.53M Buy
153,704
+59,624
+63% +$2.35M ﹤0.01% 3279
2021
Q2 		$4.15M Buy
+94,080
New +$4.1M ﹤0.01% 3508
2021
Q1 		– Sell
-29,118
Closed -$2.01M – 6229
2020
Q4 		$2.01M Buy
+29,118
New +$1.43M ﹤0.01% 3728

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Goldman Sachs's LUNG Position: Q2 2026 in Review

Goldman Sachs reduced its Pulmonx (LUNG) stake by 39% in Q2 2026, selling an estimated $121K and leaving 135,343 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #6231.

Goldman Sachs first reported a position in LUNG in Q4 2020 and has held it in 22 quarters since. The position peaked at $12.4M in Q1 2022. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Goldman Sachs held 135,343 shares of Pulmonx worth $176K as of Q2 2026.
  • Goldman Sachs sold 88,107 Pulmonx shares in Q2 2026, an estimated $121K.
  • Pulmonx made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6231 holding.
  • Goldman Sachs first reported a position in Pulmonx in Q4 2020 and has held it in 22 quarters since.
  • Goldman Sachs's Pulmonx position peaked at $12.4M in Q1 2022.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.